View Post

UTI Vaccine Only Available to Travelers

In COVID-19, Latest News by Precision Vaccinations

Many women have learned Recurrent Urinary Tract Infections (rUTIs) can be challenging to treat with antibiotics. However, an innovative oral spray-based vaccine called Uromune™ (MV140) has been found to be a viable alternative treatment.
Improved non-antibiotic management of rUTI in women represents a genuine, unmet, global medical need, stated researchers in a new study.

View Post

Testing for Mpox Clade 1 in the United States

In COVID-19, Latest News by Precision Vaccinations

There have been some recent innovative developments in disease alert systems. Previously, the first sign of a new disease reaching the United States was usually when an infected person showed up at a doctor's office.
However, the U.S. CDC's National Wastewater Surveillance System (NWSS) has proven to be a more efficient and reliable tool for detecting viruses in communities.

View Post

AI Technologies Correctly Curtail Vaccine Misconceptions

In COVID-19, Latest News by Precision Vaccinations

New research being presented at the ESCMID Global Congress shows that ChatGPT, a free-to-use, and widely accessible AI-powered chatbot, could be an effective tool in reducing vaccine hesitancy among the general public.
Even though AI chatbots like ChatGPT were introduced in late 2022, they have been struggling with accuracy issues.
Furthermore, individuals who mistrust health professionals may use technology to address their concerns.

View Post

Smallpox's Return Would Cause Global Concerns

In COVID-19, Latest News by Precision Vaccinations

An ad hoc committee under the National Academies of Sciences, Engineering, and Medicine announced a study that analyzed the lessons derived from the recent pandemic and the mpox multi-country outbreak.
The Future State of Smallpox Medical Countermeasures report argues that the United States and the global community should prepare for smallpox to make an unfortunate return. 
According to the report, smallpox could return through an accidental leak or even an intentional act.

View Post

Why Was the Maternal RSV Vaccine Study Stopped

In COVID-19, Latest News by Precision Vaccinations

Recently, a clinical trial enrollment was stopped ahead of schedule because of safety concerns. The trial's early findings indicated that the risk of severe lower respiratory tract disease in infants caused by the respiratory syncytial virus (RSV) was lower with the maternal vaccine candidate than with the placebo.
However, the risk of preterm birth was found to be higher with the candidate vaccine.